Furthermore, previous research suggests that MRSA infection may enhance metastatic potential in non–small cell lung cancer cells via Toll-like receptor 4/myeloid differentiation factor 88 signaling, implying a potential vicious cycle between MRSA infection and poor prognosis in lung cancer [8]. The gene discussed is TLR4; the disease is lung cancer.